DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
1-Year Return
22.52%
This Quarter Return
+8.55%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
-$290K
(-0.11%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-4.92%
Top 10 Holdings %
Top 10 Hldgs %
74.48%
Holding
143
New
12
Increased
13
Reduced
10
Closed
30
Top Buys
| 1 |
Panagram BBB-B CLO ETF
CLOZ
|
$15.8M |
| 2 |
Invesco AAA CLO Floating Rate Note ETF
ICLO
|
$5.87M |
| 3 |
Janus Henderson AAA CLO ETF
JAAA
|
$3.13M |
| 4 |
Sanofi
SNY
|
$2.34M |
| 5 |
Catalyst Pharmaceutical
CPRX
|
$2.11M |
Top Sells
| 1 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
$10.2M |
| 2 |
MITAW
Coliseum Acquisition Corp. Warrant
MITAW
|
$5.69M |
| 3 |
Calumet Specialty Products
CLMT
|
$4.49M |
| 4 |
FBRT
Franklin BSP Realty Trust
FBRT
|
$4.34M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$3.82M |
Sector Composition
| 1 | Materials | 30.32% |
| 2 | Healthcare | 27.82% |
| 3 | Financials | 10.27% |
| 4 | Industrials | 8.49% |
| 5 | Communication Services | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AllianceBernstein
AB
$4.36B
| $1.52M | 0.58% |
49,000
-500
| -1% | -$15.5K |
|
27
Ryman Hospitality Properties
RHP
$6.36B
| $1.32M | 0.5% |
12,000
| – | – |
|
28
Vertex Pharmaceuticals
VRTX
$102B
| $1.22M | 0.47% |
3,000
| – | – |
|
29
Protagonist Therapeutics
PTGX
$3.71B
| $1.2M | 0.46% |
52,368
| – | – |
|
30
Xenon Pharmaceuticals
XENE
$2.98B
| $1.1M | 0.42% |
23,866
| – | – |
|
31
Mondelez International
MDLZ
$78.8B
| $1.01M | 0.39% |
14,000
| – | – |
|
32
Abeona Therapeutics
ABEO
$352M
| $993K | 0.38% |
198,300
+38,300
| +24% | +$192K |
|
33
Xeris Biopharma Holdings
XERS
$1.27B
| $912K | 0.35% |
+387,910
| New | +$912K |
|
34
AbbVie
ABBV
$376B
| $781K | 0.3% |
5,037
| – | – |
|
35
Evolus
EOLS
$486M
| $769K | 0.29% |
73,066
+5,000
| +7% | +$52.6K |
|
36
DuPont de Nemours
DD
$32.3B
| $764K | 0.29% |
9,930
| – | – |
|
37
Kimberly-Clark
KMB
$42.9B
| $729K | 0.28% |
6,000
| – | – |
|
|
VRNA
38
Verona Pharma
VRNA
$9.19B
| $650K | 0.25% |
+32,672
| New | +$650K |
|
|
SYRS
39
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $623K | 0.24% |
79,927
-26,048
| -25% | -$203K |
|
40
Dow Inc
DOW
$16.9B
| $611K | 0.23% |
11,136
| – | – |
|
41
Microsoft
MSFT
$3.78T
| $602K | 0.23% |
1,600
| – | – |
|
42
Corteva
CTVA
$49.3B
| $554K | 0.21% |
11,563
| – | – |
|
43
Canadian Natural Resources
CNQ
$65.2B
| $550K | 0.21% |
16,800
| – | – |
|
44
Seres Therapeutics
MCRB
$165M
| $519K | 0.2% |
18,537
+15,037
| +430% | +$421K |
|
45
BridgeBio Pharma
BBIO
$9.91B
| $484K | 0.19% |
12,000
+3,000
| +33% | +$121K |
|
46
Apple
AAPL
$3.56T
| $480K | 0.18% |
2,494
| – | – |
|
47
Coca-Cola
KO
$294B
| $448K | 0.17% |
7,600
| – | – |
|
48
Roivant Sciences
ROIV
$8.58B
| $418K | 0.16% |
+37,200
| New | +$418K |
|
49
Xoma
XOMA
$428M
| $365K | 0.14% |
19,722
| – | – |
|
50
IBM
IBM
$230B
| $350K | 0.13% |
2,142
| – | – |
|